Please login to the form below

Not currently logged in
Email:
Password:

Foundation Medicines

This page shows the latest Foundation Medicines news and features for those working in and with pharma, biotech and healthcare.

US start-up EQRx promises approach that will slash drug prices

US start-up EQRx promises approach that will slash drug prices

in 2018 – and  Blueprint Medicines which has just claimed its first approval for a high-priced cancer drug. ... Other key figures in EQRx include former Foundation Medicine and McKesson executive Melanie Nallicheri, who serves as president and chief

Latest news

  • AstraZeneca to develop Lynparza companion diagnostic AstraZeneca to develop Lynparza companion diagnostic

    To do so AZ has joined forces with molecular information firm Foundation Medicines, whose FoundationOne genomic profiling platform will be used to develop the test. ... Nina Mojas, global medicine lead for Lynparza at AstraZeneca, said: “Utilising

  • The distance travelled

    When medicines were approved, the community thought that prices were too high and wanted a greater say in the development and delivery of medicines. ... Unimaginable thirty years ago, most companies now collaborate with not-for-profit organisations like

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Interview: Harvey Berger and Timothy Clackson, Ariad Interview: Harvey Berger and Timothy Clackson, Ariad

    treatments.”. It's the results of strategy to “discover, develop and deliver our medicines without the additional input of pharma partners”, says Berger. ... We are building a strong commercial presence, but it is one that is built on what

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....